Real-World Analysis of Patients With C3 Glomerulopathy in the United States.
Saved in:
| Title: | Real-World Analysis of Patients With C3 Glomerulopathy in the United States. |
|---|---|
| Authors: | Ndife BC; Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Aldworth C; Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Nguyen J; Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Pivneva I; Analysis Group, Boston, Massachusetts, USA., Edwards ML; Analysis Group, Boston, Massachusetts, USA., Anderson A; Analysis Group, Boston, Massachusetts, USA., Signorovitch J; Analysis Group, Boston, Massachusetts, USA., Canetta PA; Columbia University Irving Medical Center, New York, New York, USA. |
| Source: | Kidney international reports [Kidney Int Rep] 2026 Jan 14; Vol. 11 (3), pp. 103773. Date of Electronic Publication: 2026 Jan 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: eCollection Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
